The IRCND 2021 anticipates participation by many delegates including international keynote lectures and oral presentations by renowned speakers and participants. Delegates from around the world will craft a platform for global promotion and effective development in this field. The conference provides opportunities for international networking and productive collaborations with worldwide scholars.

Chair: Wanli W. Smith, MD., Ph.D.
Co-chair: Xinglong Wang, Ph.D.
Program chair: Mark R. Cookson. Ph.D.
Keynote Speaker: Erika L. F. Holzbaur, Ph.D.
Keynote Speaker: Michela Deleidi, MD, Ph.D.
Keynote Speaker: Robert Vassar, Ph.D.

IRCND 2021

We invite participants throughout the world to attend the Inaugural International Conference on Neurodegenerative Diseases (Virtual IRCND 2021), July 22-23, 2021. Given the challenges for research posed by the current pandemic, this online conference will provide an outstanding forum for invited researchers in the neurodegenerative disease field to meet, exchange ideas related to their achievements, further facilitate the understanding of pathogenesis and develop new treatments for intervention. Virtual IRCND 2021 is an inaugural conference for Global Association for the Study of Neurodegenerative Diseases (GASND). Conference registration and abstract submission is free of charge if you join the GASND.

Target Audience

Researchers, Scientists, Professors; Young Students and Fellows; Clinic researchers and physicians; Pharmaceutical companies; Foundation of Neurodegenerative diseases and other related disorders; Federal and private grant support agencies

Program Overview

Neurodegenerative diseases are characterized by the loss of function and eventual death of nerve cells in the brain or peripheral nervous system. Millions of people suffer from neurodegenerative diseases which causes overwhelmed health care support and heavy financial burden for their families and society. Currently, the pathogenesis of neurodegenerative diseases is not fully understood. There is no curative therapy.

To highlight important findings and achievements in the field and to promote exchange of information across neurodegenerative diseases, the program committee has invited well-known keynote speakers to introduce exciting presentations to our participants. The program committee has planned several themes for the conference and welcomes all participants to submit abstracts including, but not limited to, the thematic areas below. We are looking forward to learning about exciting recent findings in your laboratory!

Program themes:
A. Organelle dynamics and trafficking
Accumulating genetic and biochemical evidence links impaired organelle dynamics to neurodegenerative diseases. Established and emerging pathways include mitophagy, inter-organelle contacts, lysosome biogenesis and repair, autophagy, endosomal sorting, Golgi trafficking and synaptic vesicle trafficking.
B. Glial and Neuroinflammation
For many years, neuroinflammation has been linked to neurodegenerative diseases. Recent genetic, pathological, clinical, and biochemical investigations have reinvigorated studies positing the central role of neuroinflammation and the contribution of microglia and astrocytes in the neurodegenerative process.
C. RNA biology
Another common theme across neurodegenerative disorders is altered RNA metabolism. This includes loss of function of RNA binding proteins, impaired RNA splicing, transport and stability, alterations in microRNA and tRNA biogenesis, and changes in non-coding RNAs.
D. Protein misfolding, aggregation and spreading in neurodegenerative diseases
Despite the involvement of distinct proteins in different neurodegenerative disorders, the process of protein misfolding and aggregation is remarkably similar for different triggering proteins. Recent evidence indicates that misfolded protein aggregates can self-propagate through a seeding process and spread their pathological traits across cells and tissues, pointing to the possibility that the pathology may even be initiated outside of the central nervous system.


Young Investigator Awards are available for postdoctoral fellows and students based on scientific merit, and the quality of their abstract and presentation, as assessed by the IRCND awards committee. Applications for this award must be made online at the time of abstract submission in the IRCND conference. Applicants submitting more than one abstract for presentation during the conference, must specify which one they wish to have considered for an award. Only one abstract from each applicant is eligible for award consideration. Award-recipients will present their work during the IRCND meeting with a 10 minute talk. Award winners will be recognized in the conference program with the award certificate.

Special Section

Success on NIH grant application and review

Dr. Carol Hamelink PhD, Scientific Review Officer at Center for Scientific Review, NIH will talk about policy and new changes in NIH grant applications and the review process for all current and future NIH grantees. NIH promotes young investigators with a new type of grant, the R01 Katz application, which requires a new scientific direction for an early stage investigator as applied toward critical questions with high significance and impact in the biomedical field, but does not allow any preliminary data. This section will greatly benefit young investigators who are just starting in their career or moving in a new research direction.

Important dates

Open for abstracts: 5/5/21
Abstract deadline: 7/6/21
Registration: 5/5/21-7/16/21
Conference date: 7/22, 7/23, 8:15 Am to 1:45 Pm EST

Presentation format: Oral presentation.

Keynote speaker: 30 min (25 min talk, 5 min questions)
Key talk: 20 min (16 min talk, 4 min questions)
Regular talk: 15 min (11 min talk, 4 min questions)
Talk from young investigator: 10 min (8 min talk, 2 min questions)

Abstract Submition


2021 Organizing committee
Wanli W. Smith, MD., Ph.D. Associate Professor,
Department of Psychiatry, Johns Hopkins University School of Medicine, USA
Contact: Tel: (1)443-956-0168

Xinglong Wang, Ph.D., Professor
Department of Pharmacology and Experimental Neuroscience
College of Medicine, University Nebraska Medical Center, USA

Bobby Thomas, Ph.D., Professor
Department of Pediatrics, Neuroscience and Drug Discovery
Medical University of South Carolina, USA

Xiongwei Zhu, Ph.D., Professor
Department of Pathology
Case Western Reserve University, USA

Mark R. Cookson, Ph.D. Senior Investigator
Laboratory of Neurogenetics, NIA/NIH, USA

Yidong Bai, Ph.D., Professor
Department of Cell systems and Anatomy
University of Texas Health San Antonio, USA

Patrick Lewis, Ph.D. Professor
Department of Comparative Biomedical Sciences
The Royal Veterinary College, UK

Elisa Greggio, Ph.D. Associate Professor
Department of Biology, University of Padova, ITALY

Nicolas Arbez, Ph.D. Senior Investigator
Institut de Recherche Servier,
Neuropsychiatry Center for Therapeutic Innovation, Croissy sur Seine, France

Shaida A Andrabi, Ph.D.
The University of Alabama at Birmingham, USA

Marie-Ève Tremblay, Ph.D.
University of Victoria, Canada
Program committee
Chair: Mark R. Cookson Ph.D.

Co-Chair: Xiongwei Zhu

Co-Chair: Patrick Lewis, Ph.D.

Awards committee
Chair: Yidong Bai, Ph.D.

Co-chair: Bobby Thomas, Ph.D.

Long range planning committee
Chair: Elisa Greggio, Ph.D.

Co-chair: Nicolas Arbez, Ph.D.

Chair: Shaida A Andrabi, Ph.D.

IT and media support team
Organizes the website for abstract submission and registration and provides zoom settings for the conference presentation.
Wanli Smith
Mali Jiang
Bo Ning
Zhipeng Hou

Logistical support
Coordinates various services including registering and aiding attendees

Xinglong Wang
Ariele Peters
Justin Dunn
Amber M.Smith
© IRCDN           admin